ENTITY
3SBio Inc

3SBio Inc (1530 HK)

85
Analysis
Health CareChina
3SBio, Inc. is a biotechnology company located in China. The Company focuses on mammalian cell-based biopharmaceuticals in the biotechnology industry. 3SBio also develops, manufactures and markets biopharmaceutical products globally.
more
Refresh
02 Jan 2019 15:09

Discover HK Connect: Mainlanders Were Buying Pharma and Property Managers in December

In our Discover HK Connect series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as analyzed by...

Logo
609 Views
Share
bullishTingyi Holding
10 Dec 2018 09:10

Discover HK Connect: Mainlanders Are Buying Shandong Gold, Tingyi, YiChang HEC (2018-12-10)

In our Discover HK Connect series, we will help our investors understand the flow of southbound trades via the Hong Kong Connect, as analyzed by...

Logo
352 Views
Share
bullishM1 Ltd
30 Sep 2018 08:11

Last Week in Event SPACE: Nippon Suisan, M1, Alpine, Spring REIT, Asahi Intecc, Sinotrans Shipping

Last Week in Event SPACE ... Better than expected trial results for Amarin (AMRN US)'s Vascepa is positive for Nippon Suisan Kaisha (1332 JP) Two...

Logo
408 Views
Share
13 Sep 2018 21:13

Innovent Biologics (信达生物) IPO: A Major PD-1 MAb Competitor Might Have Just Emerged (Part 1)

Innovent Biologics is raising up to USD 500 million via a listing on the Hong Kong Stock Exchange. In this insight, we will discuss the following...

Logo
650 Views
Share
22 Jul 2018 16:09

Ascletis Pharma IPO Preview: Drug-Fuelled Euphoria Needed to Justify Valuation

Ascletis Pharma Inc (AP HK) which specialises in developing drugs to treat HCV (hepatitis C virus), HIV and liver cancer, is the first pre-profit...

Logo
736 Views
Share
x